SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to significant selling pressure, attributed to the expiration of a lock-up period releasing a large number of shares. The community is actively discussing the heavy selling at the $12 mark and debating whether this represents a buying opportunity or a sign of further decline. Comparisons to competitor Robinhood ($HOOD) and speculation about a potential short squeeze are also prominent talking points.

Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.

Above Food Ingredients Inc.

ABVE is surging as investors anticipate news related to a merger potentially backed by substantial gold assets and involvement from a Dubai royal family member. The stock's breach of the $5 level is fueling excitement, with community members speculating about a significant short squeeze and a potential run to much higher price levels. Discussions also highlight potential institutional investment and the implications of tokenizing real-world assets.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending as traders discuss the potential for a short squeeze, pointing to its high short interest and unusual options activity. Some believe the company's AI-driven drug discovery platform and partnerships with companies like NVDA could be a catalyst. Others remain cautious, noting concerns around cash burn and insider selling.

American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.

American Rebel Holdings Inc

American Rebel Holdings ($AREB) is trending amidst discussions around trading halts, potential breakout points, and the stock's history of multi-day runs. Community members are actively debating its short-squeeze potential and consolidation patterns, with some pointing to a possible 'squirt' to higher levels. Additionally, the buzz around recent biotech releases is contributing to the heightened interest in $AREB.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential for a short squeeze and await further data, particularly regarding CAN-3110. Community talking points include speculation about upcoming news, potential partnerships, and the company's valuation relative to its pipeline. Some traders express bullish sentiment, while others remain cautious, citing past performance and concerns about management.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending due to a recent $75 million investment aimed at accelerating growth in AI connectivity solutions, fueling speculation about the institutional investor behind the deal. Community members are actively discussing the potential impact on the stock price, POET's strategic position in the AI hardware ecosystem, and potential M&A opportunities. Partnerships and the potential to address bottlenecks in AI data centers are also key discussion points.

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences Inc

XBIO is trending due to a significant surge, with community members speculating about potential partnerships and pipeline advancements as catalysts. Bullish sentiment is high as traders discuss revenue growth and potential for further gains, while shorts are actively trying to suppress the stock. Some traders are also noting that this might be another short squeeze opportunity.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending amid rising gold prices, fueled by geopolitical tensions and a weakening dollar, which has some analysts predicting further gains. Community members are debating whether gold's surge indicates a broader economic downturn and whether it remains a safe haven asset given its correlation with equities. Discussions also include perspectives on inflation, potential government actions, and historical comparisons to previous market conditions.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital Corp. is trending amid discussions about its strategy to merge digital assets with oncology, specifically exploring tokenization for its mesothelioma treatment program. Community members are debating the potential of this move, with some highlighting the company's low float and others cautioning about pump-and-dump schemes. The stock's volatile price action and connection to the TON blockchain and Telegram ecosystem are also key talking points.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders debate whether the market is overvalued, with some pointing to gold's surge as a warning sign. Community members are discussing the potential impact of the government shutdown and upcoming Fed minutes, while others highlight AI's influence. Bullish sentiment remains strong, as many believe the market will continue its upward trend, while bears warn of an impending correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RF Industries Plunges 25% in a Month: Buy, Sell or Hold the Stock?

RFIL's shares have slid 24.6% this month, but strong backlog, rising margins, and growing adoption highlight a mixed outlook.


Zacks Industry Outlook Highlights Skyworks and RF Industries

RF chipmakers Skyworks and RF Industries gain from Wi-Fi 7, edge IoT, and EV demand, even as tariffs and weak end-markets pose challenges.

2 Radio Frequency Stocks to Watch in a Prospering Industry

The rapid proliferation of the edge IoT, AI data centers and automotive electrification, as well as the adoption of WiFi 6E and WiFi 7, is enhancing the prospects of SWKS and RFIL despite challenging macroeconomic conditions.


Skyworks Q3 Earnings Top Estimates, Revenues Up Y/Y, Shares Rise

SWKS jumps after fiscal Q3 earnings and revenues beat; strong Mobile demand and Android launches drive growth.


Small-Caps Stay Higher, Other Indexes Dwindle

President Trump mentioned adding new tariffs on semiconductor imports, which helped move markets aside from the Russell 2000 lower. 

Pre-markets Slightly Up on Mostly Good Q2 Earnings

Q2 earnings reports are overall posting favorable results, including this morning ahead of the open.

Skyworks to Report Q3 Earnings: What's in Store for the Stock?

SWKS' third-quarter fiscal 2025 performance is likely to have benefited from its diversified portfolio despite market challenges.


Qorvo (QRVO) Surpasses Q1 Earnings and Revenue Estimates

Qorvo (QRVO) delivered earnings and revenue surprises of +48.39% and +5.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

101 on Section 232: What it means for U.S. chip stocks

Investing.com -- The Trump administration’s Section 232 investigation into semiconductors is shaping up to be a major policy lever with potential consequences across the U.S. chip industry.

Citi adds Qorvo and Skyworks Solutions to 90-day upside catalyst watch

Investing.com -- Citi analysts have placed Qorvo (NASDAQ:QRVO) and Skyworks Solutions (NASDAQ:SWKS), Inc. on an "upside 90-day catalyst watch," anticipating better-than-expected June and September quarter results for the Apple (NASDAQ:AAPL) suppliers. 

Skyworks Solutions, Inc. engages in the development, manufacture, and provision of analog and mixed-signal semiconductor products and solutions for applications including aerospace, automotive, broadband, cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, smartphone, tablet, and wearables. Its products include amplifiers, attenuators, circulators, demodulators, detectors, diodes, directional couplers, front-end modules, hybrids, isolators, lighting and display solutions, mixers, modulators, optocouplers, opt isolators, phase shifters, synthesizers, power dividers and combiners, receivers, switches, and technical ceramics. The company was founded in 1962 and is headquartered in Irvine, CA.

Skyworks Solutions, Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$75.64
Prev Close	$74.34
Open	$74.45
Dividend Yield	2.77%
50-Day Moving Average	$74.60
Beta	1.61
Avg. Volume	2.78M
PE Ratio	29.62

52-Week High	$101.50
52-Week Low	$47.93
Market Capitalization	$11.03B
EPS (Annual)	$3.69
Price to Book	1.95
Revenue Per Employee	$413,663.37
Enterprise Value/EBITDA	N/A

SWKS
Skyworks Solutions, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SWKS News

SWKS Skyworks Solutions, Inc.